Findings

What do systematic reviews say?

2 questions · 4 findings · 1 reviews

No studies found 1 · 25%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 1 · 25%High 0 · 0%

Rate of serious adverse events · adults (≥ 18 years of age) with a diagnosis of chronic heart failure with reduced ejection fraction (HFrEF)

2 findings from 1 review

Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 270 participants
Low
Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
RR 0.96 [0.92, 1]
2 studies · 17399 participants
Moderate

Rate of serious adverse events · patients with chronic heart failure with preserved ejection fraction

2 findings from 1 review

Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 179 participants
Low
Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found